Quantifying the benefits of intensive lipid lowering in ASCVD

Sponsored by sanofi aventis Australia Pty Ltd

A recent virtual education meeting provided insights from landmark lipid lowering trials on the benefits of intensive LDL-C reduction in patients with atherosclerotic cardiovascular disease (ASCVD). The sponsored educational meeting featured discussion led by renowned Cardiologist Professor Shaun Goodman, Associate Head in the Division of Cardiology, Department of Medicine, at St. Michael’s Hospital and University ...

Already a member?

Login to keep reading.

© 2021 the limbic